Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by LithLoveron Jan 07, 2021 10:29am
346 Views
Post# 32241530

RE:RE:RE:RE:Nice presentation this morning from StageZero

RE:RE:RE:RE:Nice presentation this morning from StageZero"Launch and market Aristotle in Q1 2021".

With only 12 weeks left in Q1, for Tripp to be presenting that statement is a very good sign.  He's not saying first half of the year or in 2021 but to be in Q1 and say Q1 2021 is very very positive.

 
RelevantStock wrote: "We had a very good Q4, we're very pleased with it".

"1.5M was not spectacular, but it was a good beginning."

I love all of these, nice action this morning.  I think the game plan for Aristotle is very well thought too, I like how they want to reach directly the constumer / patient, I find this to be very innovative in healthcare.


<< Previous
Bullboard Posts
Next >>